Acknowledgments
The authors thank the structural heart disease Heart Team at St.
Marianna University School of Medicine Hospital for their assistance.
References
1. Dini FL, Conti U, Fontanive P et al. Right ventricular dysfunction is
a major predictor of outcome in patients with moderate to severe mitral
regurgitation and left ventricular dysfunction. Am Heart J
2007;154:172-9.
2. Merlo M, Gobbo M, Stolfo D et al. The Prognostic Impact of the
Evolution of RV Function in Idiopathic DCM. JACC Cardiovasc Imaging
2016;9:1034-1042.
3. Dahou A, Clavel MA, Capoulade R et al. Right ventricular longitudinal
strain for risk stratification in low-flow, low-gradient aortic stenosis
with low ejection fraction. Heart 2016;102:548-54.
4. Gorter TM, Lexis CP, Hummel YM et al. Right Ventricular Function
After Acute Myocardial Infarction Treated With Primary Percutaneous
Coronary Intervention (from the Glycometabolic Intervention as Adjunct
to Primary Percutaneous Coronary Intervention in ST-Segment Elevation
Myocardial Infarction III Trial). Am J Cardiol 2016;118:338-44.
5. Sanz J, Sanchez-Quintana D, Bossone E, Bogaard HJ, Naeije R. Anatomy,
Function, and Dysfunction of the Right Ventricle: JACC State-of-the-Art
Review. J Am Coll Cardiol 2019;73:1463-1482.
6. Sabe MA, Sabe SA, Kusunose K, Flamm SD, Griffin BP, Kwon DH.
Predictors and Prognostic Significance of Right Ventricular Ejection
Fraction in Patients With Ischemic Cardiomyopathy. Circulation
2016;134:656-65.
7. Kaneko H, Neuss M, Weissenborn J, Butter C. Prognostic Significance
of Right Ventricular Dysfunction in Patients With Functional Mitral
Regurgitation Undergoing MitraClip. Am J Cardiol 2016;118:1717-1722.
8. Giannini C, Petronio AS, De Carlo M et al. Integrated reverse left
and right ventricular remodelling after MitraClip implantation in
functional mitral regurgitation: an echocardiographic study. Eur Heart J
Cardiovasc Imaging 2014;15:95-103.
9. Frangieh AH, Gruner C, Mikulicic F et al. Impact of percutaneous
mitral valve repair using the MitraClip system on tricuspid
regurgitation. EuroIntervention 2016;11:e1680-6.
10. Vitarelli A, Mangieri E, Capotosto L et al. Assessment of
Biventricular Function by Three-Dimensional Speckle-Tracking
Echocardiography in Secondary Mitral Regurgitation after Repair with the
MitraClip System. J Am Soc Echocardiogr 2015;28:1070-82.
11. Zoghbi WA, Enriquez-Sarano M, Foster E et al. Recommendations for
evaluation of the severity of native valvular regurgitation with
two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr
2003;16:777-802.
12. Zoghbi WA, Adams D, Bonow RO et al. Recommendations for Noninvasive
Evaluation of Native Valvular Regurgitation: A Report from the American
Society of Echocardiography Developed in Collaboration with the Society
for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr
2017;30:303-371.
13. Lancellotti P, Tribouilloy C, Hagendorff A et al. Recommendations
for the echocardiographic assessment of native valvular regurgitation:
an executive summary from the European Association of Cardiovascular
Imaging. Eur Heart J Cardiovasc Imaging 2013;14:611-44.
14. Rudski LG, Lai WW, Afilalo J et al. Guidelines for the
echocardiographic assessment of the right heart in adults: a report from
the American Society of Echocardiography endorsed by the European
Association of Echocardiography, a registered branch of the European
Society of Cardiology, and the Canadian Society of Echocardiography. J
Am Soc Echocardiogr 2010;23:685-713; quiz 786-8.
15. Anavekar NS, Gerson D, Skali H, Kwong RY, Yucel EK, Solomon SD.
Two-dimensional assessment of right ventricular function: an
echocardiographic-MRI correlative study. Echocardiography 2007;24:452-6.
16. Stone GW, Adams DH, Abraham WT et al. Clinical Trial Design
Principles and Endpoint Definitions for Transcatheter Mitral Valve
Repair and Replacement: Part 2: Endpoint Definitions: A Consensus
Document From the Mitral Valve Academic Research Consortium. J Am Coll
Cardiol 2015;66:308-321.
17. Aloia E, Cameli M, D’Ascenzi F, Sciaccaluga C, Mondillo S. TAPSE: An
old but useful tool in different diseases. Int J Cardiol
2016;225:177-183.
18. Mehta SR, Eikelboom JW, Natarajan MK et al. Impact of right
ventricular involvement on mortality and morbidity in patients with
inferior myocardial infarction. J Am Coll Cardiol 2001;37:37-43.
19. Polak JF, Holman BL, Wynne J, Colucci WS. Right ventricular ejection
fraction: an indicator of increased mortality in patients with
congestive heart failure associated with coronary artery disease. J Am
Coll Cardiol 1983;2:217-24.
20. Gavazzi A, Berzuini C, Campana C et al. Value of right ventricular
ejection fraction in predicting short-term prognosis of patients with
severe chronic heart failure. J Heart Lung Transplant 1997;16:774-85.
21. Shah PK, Maddahi J, Staniloff HM et al. Variable spectrum and
prognostic implications of left and right ventricular ejection fractions
in patients with and without clinical heart failure after acute
myocardial infarction. Am J Cardiol 1986;58:387-93.
22. Juilliere Y, Barbier G, Feldmann L, Grentzinger A, Danchin N,
Cherrier F. Additional predictive value of both left and right
ventricular ejection fractions on long-term survival in idiopathic
dilated cardiomyopathy. Eur Heart J 1997;18:276-80.
23. Wencker D, Borer JS, Hochreiter C et al. Preoperative predictors of
late postoperative outcome among patients with nonischemic mitral
regurgitation with ’high risk’ descriptors and comparison with
unoperated patients. Cardiology 2000;93:37-42.
24. Meluzin J, Spinarova L, Hude P et al. Prognostic importance of
various echocardiographic right ventricular functional parameters in
patients with symptomatic heart failure. J Am Soc Echocardiogr
2005;18:435-44.
25. Giannini C, Fiorelli F, Colombo A et al. Right ventricular
evaluation to improve survival outcome in patients with severe
functional mitral regurgitation and advanced heart failure undergoing
MitraClip therapy. Int J Cardiol 2016;223:574-580.
26. Orban M, Braun D, Orban M et al. Long-term outcome of patients with
severe biventricular heart failure and severe mitral regurgitation after
percutaneous edge-to-edge mitral valve repair. J Interv Cardiol
2015;28:164-71.
27. Bazaz R, Edelman K, Gulyasy B, Lopez-Candales A. Evidence of robust
coupling of atrioventricular mechanical function of the right side of
the heart: insights from M-mode analysis of annular motion.
Echocardiography 2008;25:557-61.
28. Mohammed SF, Hussain I, AbouEzzeddine OF et al. Right ventricular
function in heart failure with preserved ejection fraction: a
community-based study. Circulation 2014;130:2310-20.
29. Bursi F, McNallan SM, Redfield MM et al. Pulmonary pressures and
death in heart failure: a community study. J Am Coll Cardiol
2012;59:222-31.
30. Kjaergaard J, Akkan D, Iversen KK et al. Prognostic importance of
pulmonary hypertension in patients with heart failure. Am J Cardiol
2007;99:1146-50.
31. Alexopoulos D, Lazzam C, Borrico S, Fiedler L, Ambrose JA. Isolated
chronic mitral regurgitation with preserved systolic left ventricular
function and severe pulmonary hypertension. J Am Coll Cardiol
1989;14:319-22.
32. Setaro JF, Cleman MW, Remetz MS. The right ventricle in disorders
causing pulmonary venous hypertension. Cardiol Clin 1992;10:165-83.
33. Kubba S, Davila CD, Forfia PR. Methods for Evaluating Right
Ventricular Function and Ventricular-Arterial Coupling. Prog Cardiovasc
Dis 2016;59:42-51.
34. Vonk-Noordegraaf A, Haddad F, Chin KM et al. Right heart adaptation
to pulmonary arterial hypertension: physiology and pathobiology. J Am
Coll Cardiol 2013;62:D22-33.
35. Cavalcante JL, Simon MA, Chan SY. Comprehensive Right-Sided
Assessment for Transcatheter Aortic Valve Replacement Risk
Stratification: Time for a Change. J Am Soc Echocardiogr 2017;30:47-51.
36. Hussain I, Mohammed SF, Forfia PR et al. Impaired Right
Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in
Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis
From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And
Exercise Capacity in Diastolic Heart Failure (RELAX) Trial. Circ Heart
Fail 2016;9:e002729.
37. Sultan I, Cardounel A, Abdelkarim I et al. Right ventricle to
pulmonary artery coupling in patients undergoing transcatheter aortic
valve implantation. Heart 2019;105:117-121.
38. Maisano F, Franzen O, Baldus S et al. Percutaneous mitral valve
interventions in the real world: early and 1-year results from the
ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study
of the MitraClip therapy in Europe. J Am Coll Cardiol 2013;62:1052-1061.
39. Glower DD, Kar S, Trento A et al. Percutaneous mitral valve repair
for mitral regurgitation in high-risk patients: results of the EVEREST
II study. J Am Coll Cardiol 2014;64:172-81.
40. Sorajja P, Vemulapalli S, Feldman T et al. Outcomes With
Transcatheter Mitral Valve Repair in the United States: An STS/ACC TVT
Registry Report. J Am Coll Cardiol 2017;70:2315-2327.
41. Hunlich M, Lubos E, Beuthner BE et al. Acute and Long-Term
Hemodynamic Effects of MitraClip Implantation on a Preexisting Secondary
Right Heart Failure. Biomed Res Int 2018;2018:6817832.
42. Ledwoch J, Fellner C, Hoppmann P et al. Impact of transcatheter
mitral valve repair using MitraClip on right ventricular remodeling. Int
J Cardiovasc Imaging 2020.